{"transactions":[{"id":3340575,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":153097,"kind":"person","name":"Kwon Paul","position":1,"cik":"0001727717","reported_name":"Kwon Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2019-12-16T22:13:19.000Z","date":"2019-12-11","kind":"exercise","acquired":false,"shares":80300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units, (\"RSUs\"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units, (\"RSUs\"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units, (\"RSUs\"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":80300},"source":{"system":"sec-edgar","filing":"0000899243-19-029291","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000089924319029291/doc4a.xml","form_type":"4/A","original_submission_date":"2019-12-16"}},{"id":3340574,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":153097,"kind":"person","name":"Kwon Paul","position":1,"cik":"0001727717","reported_name":"Kwon Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-12-16T22:13:19.000Z","date":"2019-12-11","kind":"tax_withholding","acquired":false,"shares":27766,"price":4.52,"value":125502.32,"ownership":{"direct":true},"balance_after":52534,"source":{"system":"sec-edgar","filing":"0000899243-19-029291","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000089924319029291/doc4a.xml","form_type":"4/A","original_submission_date":"2019-12-16"}},{"id":3340573,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":153097,"kind":"person","name":"Kwon Paul","position":1,"cik":"0001727717","reported_name":"Kwon Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2019-12-16T22:13:19.000Z","date":"2019-12-11","kind":"exercise","acquired":true,"shares":80300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units, (\"RSUs\"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code."}],"balance_after":80300,"source":{"system":"sec-edgar","filing":"0000899243-19-029291","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000089924319029291/doc4a.xml","form_type":"4/A","original_submission_date":"2019-12-16"}},{"id":3342061,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":153097,"kind":"person","name":"Kwon Paul","position":1,"cik":"0001727717","reported_name":"Kwon Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2019-12-14T02:59:09.000Z","date":"2019-12-11","kind":"tax_withholding","acquired":false,"shares":27766,"price":4.52,"value":125502.32,"ownership":{"direct":true},"balance_after":52534,"source":{"system":"sec-edgar","filing":"0000899243-19-029192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000089924319029192/doc4.xml","form_type":"4"}},{"id":3342060,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":153097,"kind":"person","name":"Kwon Paul","position":1,"cik":"0001727717","reported_name":"Kwon Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2019-12-14T02:59:09.000Z","date":"2019-12-11","kind":"exercise","acquired":true,"shares":80300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units, (\"RSUs\"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code."}],"balance_after":80300,"source":{"system":"sec-edgar","filing":"0000899243-19-029192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000089924319029192/doc4.xml","form_type":"4"}},{"id":3444289,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":153097,"kind":"person","name":"Kwon Paul","position":1,"cik":"0001727717","reported_name":"Kwon Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2019-08-07T23:29:07.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":80300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in two (2) equal annual installments beginning July 29, 2020, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":396812,"derivative":{"underlying":"Common Stock","underlying_shares":80300},"source":{"system":"sec-edgar","filing":"0000899243-19-021298","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000089924319021298/doc4a.xml","form_type":"4/A","original_submission_date":"2019-07-31"}},{"id":3451817,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":153097,"kind":"person","name":"Kwon Paul","position":1,"cik":"0001727717","reported_name":"Kwon Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-07-31T22:33:25.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":80300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in two (2) equal annual installments beginning July 29, 2020, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":396812,"derivative":{"underlying":"Common Stock","underlying_shares":80300},"source":{"system":"sec-edgar","filing":"0000899243-19-020701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000089924319020701/doc4.xml","form_type":"4"}},{"id":3733662,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":153097,"kind":"person","name":"Kwon Paul","position":1,"cik":"0001727717","reported_name":"Kwon Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2018-12-12T23:43:09.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly."}],"balance_after":64000,"derivative":{"exercise_price":5.51,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001566044-18-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000156604418000012/edgardoc.xml","form_type":"4"}},{"id":3945287,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":153097,"kind":"person","name":"Kwon Paul","position":1,"cik":"0001727717","reported_name":"Kwon Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2018-05-04T20:36:16.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly."}],"balance_after":252512,"derivative":{"exercise_price":8.49,"expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001209191-18-028123","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919118028123/doc4.xml","form_type":"4"}}]}